Adaptive Biotechnologies Corporation (ADPT) vs Personalis, Inc. (PSNL)
- Adaptive Biotechnologies Corporation ADPT 24.02 −6.10%
- Personalis, Inc. PSNL 15.65 −1.76%
Adaptive Biotechnologies Corporation and Personalis, Inc. are both Diagnostics & Research companies. Adaptive Biotechnologies Corporation is the larger, with a market value of $4.1B against $1.7B — 2.4× the size. Adaptive Biotechnologies Corporation grew revenue faster over the last twelve months: 50.1% against −13.3%. Adaptive Biotechnologies Corporation has the higher net margin (−20.7% vs −153.8%) and the higher return on invested capital (−16.6% vs −317.5%). Across the 18 metrics below, Adaptive Biotechnologies Corporation leads on 14 and Personalis, Inc. on 4.
Valuation
Profitability
| Metric | ADPT | PSNL | Diagnostics & Research median |
|---|---|---|---|
| Gross margin | 75.57% | 12.69% | 50.89% |
| Operating margin | (12.16%) | (164.07%) | (8.57%) |
| Net margin | (20.73%) | (153.84%) | (6.37%) |
| Free cash flow margin | (7.80%) | (144.76%) | 0.00% |
| Return on equity | (38.68%) | (50.32%) | (2.92%) |
| Return on assets | (11.23%) | (37.55%) | (6.71%) |
| Return on invested capital | (16.57%) | (317.48%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack